{"name":"Kenai Therapeutics","slug":"kenai-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNUjJFYWhoMF9TbmU4azVkRklKYmJKR3ZoVkd1clhJcEVYU09ENUpfUXNvX2FOY0xVOUNNUF9qNGlSZkxtbXRPOWV4MTZrWU0tNEpvLVpwMVU0cXVibkl5N21wb1RyemJsRllFV1lndFhKQndEcWFnRzd0R0xGcUJiblpjb2N3TnBIS1k3c2tEelQ0MDk5QVhaUGR3Mlk1c28tS09rSmoxeXQtLW5lWGg0NGFQSk0weHViOWNB?oc=5","date":"2026-03-12","type":"pipeline","source":"PR Newswire","summary":"Kenai Therapeutics Appoints Allen Waldrop to Board of Directors - PR Newswire","headline":"Kenai Therapeutics Appoints Allen Waldrop to Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1IWGt0aHk5LV9Ra2l3Z2FqQXB5am1RODZZaVIydHJvM2ZMX2R6bFJ4R0VGWjAwU25CdkYzY1VocnAwcGpTcnJTNXhYVU9zanB6Sk5pbE9NVk1OMURLeHM3VEdkWGRlcnPSAWxBVV95cUxOV05WRWNUVmU1Zy1QRzNXQlBwQjlUb2xieU91ekx1SmNQcXEwQ2dxVkxtaThLd21uUzFiaE1pWEVZVVJ3dUQ1RjNTelpyb3hyLVlHa3ZyT3Y5c0ZTQUM2MFRaTFNEYkp2X2E0N3c?oc=5","date":"2026-03-05","type":"pipeline","source":"BioInformant","summary":"The Pipeline for iPSC-Derived Cell Therapeutics in 2026 - BioInformant","headline":"The Pipeline for iPSC-Derived Cell Therapeutics in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNdW52S1Q0a0g2V1dOa2diZF9heTVsWXFBZFJHanRocU5fTmRUckFyVXdsQTA0TlBfZHN0NHVQWmFtMVFhWVR0TTZVbFJvY3RrTURNMl9UY0Y1RmRYLXBjWVFQYURjX3pJM19wRkYxYjBGOHFlS0JGUnFNaTZiVkJPSUZHb2taU1pqQ29QVDBhSjJoTFB2UU5nVnhiT1dZT1hyMW5ERXhqNTIwWVhvZ09NVkxpU3R3THdzLUE?oc=5","date":"2026-02-27","type":"trial","source":"Endpoints News","summary":"Doug Ingram’s uneven legacy at Sarepta; Merck splits human health business, brings in Sanofi exec - Endpoints News","headline":"Doug Ingram’s uneven legacy at Sarepta; Merck splits human health business, brings in Sanofi exec","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPbHBvWVZZTm5BOThndXQybzF0ZENDRWhtOG1xN3pGNDB6endZdHlsQzdjMXVmQkI3czl2WkpNVFVDckpzTkZIWmV2NlV2QUFVNUswQV9EX1hKTllaZDF2TmVrSG13TTcwYWcxMm9CNVUtREFlaGxDWEstM2g0R2lzTjV5UmFpQ3dEMHhwOUZpQmxiNHJtUHZIeGc4NlJORmVaT0hnY1F4MFVLbE5EWVhN?oc=5","date":"2026-02-24","type":"pipeline","source":"BioSpace","summary":"Kenai Therapeutics Appoints Blake Arnold, CFA, as Chief Business Officer - BioSpace","headline":"Kenai Therapeutics Appoints Blake Arnold, CFA, as Chief Business Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFBSNUNWX2RoMDg3bTExdDlLY21INVZRNFJpUGQ2QlNCYzhNRDJPTVlmMXhacXdyY05zSWtTYThSdEEtZElsbjVyMzhRQ2hSWHI3dXk5R1pxbDJ3NzJfM0E0UHk4cVZNellkdS0zenFlZ1FTQQ?oc=5","date":"2025-12-16","type":"trial","source":"Clinical Trials Arena","summary":"Kenai doses first patient in Phase I trial of cell therapy for Parkinson’s - Clinical Trials Arena","headline":"Kenai doses first patient in Phase I trial of cell therapy for Parkinson’s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxObVFVTWdOU2hITElUek5tSnd0cGttMVJ5S3FOVXFkazEyUVZXX1NnOHpyVGJqbTBDZzBGSnU3QlF1NlJZdHlqaklmSWg4dHRmcDNYY1lBMU9xd3ptQVlhY04wVlg2Z3RKT3k4WXdNb18xVTdkZTAtdEJrVVhOTHY3WVhuYm5rOVVWTW5vTXpqbm1obWNjdFdCNlJGSDhsTm1OVExFYl9hYlZWM240eldzc1kxWU1uZUlIZ1NiS0JNX3FZTnBwX0oxbTEwNjdvdVdxNXBFaXhFa0gyYWV1MnczQlUyc00wNDVUcnh4bUtkY2Frb1dkQlpXZ1ltdWhCN05yWjJmYnMtcWdLTWdZend5eVdneWRDWWViWDBwSGxrQmpNaFg0RFRjeWxoZFhBWnFZOHJuMnRMWGVuY3ZD?oc=5","date":"2025-12-15","type":"trial","source":"PR Newswire","summary":"Kenai Therapeutics Announces First Patient Dosed in Phase 1 REPLACE™ Clinical Trial of Neuron Replacement Cell Therapy RNDP-001 for Idiopathic Parkinson's Disease - PR Newswire","headline":"Kenai Therapeutics Announces First Patient Dosed in Phase 1 REPLACE™ Clinical Trial of Neuron Replacement Cell Therapy R","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPYkZfemF0OHFWYjJ2Vkc1UzNDajE2Q0U4bHJpYUw0TklnSEVEckR2SGwwWnJsWFNDMlNkak84NTBhZDc4eVJQRzR4dkdFbTRyaUd1VkZCdzdLUU5BS1VqQTZteUJqTENpUUQ2N0dQbEQzU3phTFV2aDQtRnNwZUhCbTdn?oc=5","date":"2025-09-30","type":"pipeline","source":"businessofsandiego.substack.com","summary":"Eli Lilly Celebrates Grand Opening of Gateway Labs Incubator in Torrey Pines - businessofsandiego.substack.com","headline":"Eli Lilly Celebrates Grand Opening of Gateway Labs Incubator in Torrey Pines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQWWNKTlVHazVXc2plWHU4d3E1MVUzYjZ4dXh2aW8xR2hPNERsdWV3Uy1XQ3IzSFA0VEt4NlFGUnp1aFp3VW1JeGpqSjBqZmVORVNxTG9CVVAydFRxbzlzYm1CcnlWMkxPS1BicDk5N21oZElpekJkamhIZGZfUE5xZDN6ay1WN3E2WFM5N2QyY3ZPMGZHelVwOUZiaGUwUXFST0l3OFkyM2lNTWM?oc=5","date":"2025-02-18","type":"pipeline","source":"Parkinson's News Today","summary":"Kenai facility will advance Parkinson's neuron replacement therapy research - Parkinson's News Today","headline":"Kenai facility will advance Parkinson's neuron replacement therapy research - Parkinson's News Today","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNa1JjM3ktRGY3MFptQUlsdFJyYTZGQmYwQnBaZm41S3NpZGIwWkVQbVdyNURPdEtVNXNDaXRwbnJ6d2lreUN3UmtHYmd0dlFWYUhSd1ljVHBpS2trRHQ4elNEdVRrbThiTTk1REhsSU1jLW5pU0tlQ21oa2dtbUcweHNJTVFfX1F4b0JBR0VPYmRZdjNVMlQ4eUdmRTJWSmY3Y1c4SEJiWldycjdSTjdZ?oc=5","date":"2025-02-12","type":"pipeline","source":"BioSpace","summary":"Kenai Therapeutics Establishes Research Facility at Lilly Gateway Labs - BioSpace","headline":"Kenai Therapeutics Establishes Research Facility at Lilly Gateway Labs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNU3BLdC1qbVJSejMzbUY1REMxRk9aQk1ETnNnVjJyZTU4dWNjQi00bUQ4QlBFRnl5eEVnekt4VzZsQTVlVjA2dWxSRU04eE5RNHJuT3VTOEwtelZtMEU4TTZEblJNS0xiME9Ba1pyTHh1RUdVOHFmUGh0N2NIR1lhbFEzMHR4aUhLNHA3X3Q3aV9JbjM0Qktz?oc=5","date":"2024-02-29","type":"pipeline","source":"BioPharma Dive","summary":"Cure Ventures backs a cell therapy startup targeting Parkinson’s - BioPharma Dive","headline":"Cure Ventures backs a cell therapy startup targeting Parkinson’s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxObEJZM2hJTGVUbF9IMmJIRG5XV0ZHTk9EZXRMNldoOGxRaTlwMENaQTdaREdrd2xOM3Y4Yno0SGxWOTRUelNjcEN4WnJLek0xSzZVd3B4N0RyRVowbFpTdmNOZ2ZvNVpTY05WT29HSWFqeExJTjBYbVllRGNMUnZsY2ZQNC1KU0htTzcxS2pGSXBmZHVNRGNGM19SV3NyS3hreE40emo0MnZ0enZDdGNjMEsxZjdoQ2U1aURya05fMUdNSmRTdEt4S1UwZTFqNGo2a1JIeWFpNFp5RHpzUjhWMGpYY3hBcEhFdU1QNmRFZks0RHNLLXpjWC1vTTZiM2Z4N0NTeU5LcGFCdEQ3cXZDc3pXbHFoS29IOWl1VmVDN2p6Zjg?oc=5","date":"2024-02-29","type":"pipeline","source":"Business Wire","summary":"Kenai Therapeutics Announces $82 Million Series A Financing to Advance Next Generation Allogeneic Cell Therapies for Neurological Diseases - Business Wire","headline":"Kenai Therapeutics Announces $82 Million Series A Financing to Advance Next Generation Allogeneic Cell Therapies for Neu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPb1QzMVBhdFpIanVwMzFGQ3l6Z3pDNUJxdVNzeEkwSXNUa2RkeXFnRndwdDNUSnhsRDltRlkwVzRxMnZvU2poVGQtX1drR1RESVZ1UWt4d2g1bkpKUVA1cHhpV1BfTGhfSmQtaXhBSUFWTEFaWjV3XzBvR2J0dVFxdlhKOFVYb2otT0VnUlJDR0kya29xUXM4?oc=5","date":"2024-02-29","type":"pipeline","source":"statnews.com","summary":"Biotech launches with $82 million for Parkinson’s cell therapy - statnews.com","headline":"Biotech launches with $82 million for Parkinson’s cell therapy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}